Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1989 1
1991 11
1992 24
1993 28
1994 29
1995 59
1996 48
1997 36
1998 42
1999 34
2000 45
2001 36
2002 46
2003 35
2004 41
2005 40
2006 36
2007 38
2008 28
2009 28
2010 37
2011 50
2012 39
2013 56
2014 45
2015 44
2016 45
2017 46
2018 35
2019 33
2020 9
Text availability
Article attribute
Article type
Publication date

Search Results

1,030 results
Results by year
Filters applied: . Clear all
Page 1
Levonorgestrel-releasing intrauterine system (LNG-IUS 12) for prevention of pregnancy for up to five years.
Nelson AL. Nelson AL. Expert Rev Clin Pharmacol. 2017 Aug;10(8):833-842. doi: 10.1080/17512433.2017.1341308. Epub 2017 Jun 19. Expert Rev Clin Pharmacol. 2017. PMID: 28617060 Review.
An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC. Chi IC. Contraception. 1991 Dec;44(6):573-88. doi: 10.1016/0010-7824(91)90078-t. Contraception. 1991. PMID: 1773615 Review.
Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action.
Ortiz ME, Croxatto HB. Ortiz ME, et al. Contraception. 2007 Jun;75(6 Suppl):S16-30. doi: 10.1016/j.contraception.2007.01.020. Epub 2007 Mar 29. Contraception. 2007. PMID: 17531610 Review.
Hair loss with use of the levonorgestrel intrauterine device.
Paterson H, Clifton J, Miller D, Ashton J, Harrison-Woolrych M. Paterson H, et al. Contraception. 2007 Oct;76(4):306-9. doi: 10.1016/j.contraception.2007.06.015. Epub 2007 Aug 28. Contraception. 2007. PMID: 17900442
Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants.
Sivin I. Sivin I. Drug Saf. 2003;26(5):303-35. doi: 10.2165/00002018-200326050-00002. Drug Saf. 2003. PMID: 12650633 Review.
Progestin and breast cancer risk: a systematic review.
Samson M, Porter N, Orekoya O, Hebert JR, Adams SA, Bennett CL, Steck SE. Samson M, et al. Breast Cancer Res Treat. 2016 Jan;155(1):3-12. doi: 10.1007/s10549-015-3663-1. Epub 2015 Dec 23. Breast Cancer Res Treat. 2016. PMID: 26700034 Free PMC article. Review.
Levonorgestrel only emergency contraceptive use and risk of ectopic pregnancy in Eldoret Kenya: a case-control study.
Shurie S, Were E, Orang'o O, Keter A. Shurie S, et al. Pan Afr Med J. 2018 Nov 29;31:214. doi: 10.11604/pamj.2018.31.214.17484. eCollection 2018. Pan Afr Med J. 2018. PMID: 31447973 Free PMC article.
A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
Bahamondes L, Brache V, Ali M, Habib N; WHO study group on contraceptive implants for women. Bahamondes L, et al. Contraception. 2018 Sep;98(3):181-187. doi: 10.1016/j.contraception.2018.05.009. Epub 2018 May 16. Contraception. 2018. PMID: 29777663 Clinical Trial.
Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System.
Teal SB, Turok DK, Chen BA, Kimble T, Olariu AI, Creinin MD. Teal SB, et al. Obstet Gynecol. 2019 Jan;133(1):63-70. doi: 10.1097/AOG.0000000000003034. Obstet Gynecol. 2019. PMID: 30531565 Free PMC article. Clinical Trial.
A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena.
Gemzell-Danielsson K, Schellschmidt I, Apter D. Gemzell-Danielsson K, et al. Fertil Steril. 2012 Mar;97(3):616-22.e1-3. doi: 10.1016/j.fertnstert.2011.12.003. Epub 2012 Jan 4. Fertil Steril. 2012. PMID: 22222193 Clinical Trial.
1,030 results
Jump to page
Feedback